Financhill
Back

Royal Caribbean Group Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
59

RCL
Royal Caribbean Group

Last Price:
$207.26
Seasonality Move:
7.77%
Buy
54

SRPT
Sarepta Therapeutics

Last Price:
$99.80
Seasonality Move:
6.73%
Buy
59
Royal Caribbean Group (RCL) is a Buy

Is Royal Caribbean Group a Buy, Sell or Hold?

  • The current Royal Caribbean Group [RCL] share price is $207.17. The Score for RCL is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • RCL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
54
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $100.71. The Score for SRPT is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

RCL Stock Price Chart

What is Royal Caribbean Group's stock price today?

  • The Royal Caribbean Group share price today is $207.17
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RCL is experiencing slight buying pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $100.71
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

RCL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -9 Sell
Relative Strength Index (14 RSI): 30.29 Sell
Chaikin Money Flow: 2212473 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (229.86 - 265.82) Sell
Bollinger Bands (100): (214.72 - 254) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.22 Sell
Relative Strength Index (14 RSI): 38.38 Sell
Chaikin Money Flow: 544784 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (103.87 - 112.63) Sell
Bollinger Bands (100): (110.05 - 127.23) Sell

RCL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 227.55 Sell
20-day SMA: 243.39 Sell
50-day SMA: 242.68 Sell
200-day SMA: 197.4 Buy
8-day EMA: 224.34 Sell
20-day EMA: 236.78 Sell
50-day EMA: 239.95 Sell
200-day EMA: 203.66 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 103.91 Sell
20-day SMA: 106.68 Sell
50-day SMA: 114.29 Sell
200-day SMA: 126.68 Sell
8-day EMA: 104.06 Sell
20-day EMA: 106.89 Sell
50-day EMA: 112.29 Sell
200-day EMA: 121 Sell

Royal Caribbean Group Earnings Growth & RCL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.92 per share, a decrease next quarter of $2.84 per share, an increase this year of $3.22 per share, and an increase next year of $2.71 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.52 per share, an increase next quarter of $0.05 per share, an increase this year of $6.65 per share, and an increase next year of $5.25 per share.

Royal Caribbean Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):